Sign in

Farzana Ali, MD PhD MPH

@fzali.bsky.social
4 followers 25 following 14 posts

Nuclear Medicine and Theranostics UCLA

PostsRepliesMedia
Farzana Ali, MD PhD MPH @fzali.bsky.social · 26/09/2026
Just wanted to take a moment to reflect on how much it means to me to have received the 2026 Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety from the Education and Research Foundation (#ERF) for our work on post Y-90 radioembolization. Thanks to @snm-mi.bsky.social for the opportunity.
Certificate from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Title: Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety. Presented to Farzana Ali, MD, PhD, MPH, for the abstract "Dosimetry Predictors of Hepatic Injury after Y-90 Radioembolization: Insights from PET, MRI, and Biochemical Markers".
110
Reposted by Farzana Ali, MD PhD MPH
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 12/08/2026
New from the Vasty Deep: A warm welcome to our new cohort of trainee editorial board members radiologyai.substack.com/p/welcome-… #Welcome #EditorialBoard #ML
Image from article in Radiology: Artificial Intelligence
042
Farzana Ali, MD PhD MPH @fzali.bsky.social · 21/07/2026
The highlight of my #SNMMI26 experience was the time spent with these remarkable women from the UCLA Department of #NuclearMedicine and #Theranostics. 💙 Thanks to @snm-mi.bsky.social and @uofcalifornia.bsky.social #LA for fostering an environment where collaboration and mentorship thrive. 🌟
Five colleagues from the UCLA Department of Nuclear Medicine and Theranostics pose together inside the convention center at the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. Each person is wearing a conference badge. Large SNMMI meeting signage, convention hall architecture, and informational displays are visible in the background. The photo captures a moment of collegiality and community during a scientific meeting focused on advances in nuclear medicine and molecular imaging.
021
Reposted by Farzana Ali, MD PhD MPH
AACR Journals @aacrjournals.bsky.social · 15/03/2026
The AACR Journals offers the Guaranteed Peer Review program. Members who peer review at least three manuscripts for one or more AACR journals can qualify to have their own submitted manuscript be automatically sent for external peer review. Learn more: buff.ly/mivP542
001
Reposted by Farzana Ali, MD PhD MPH
The ASCO Post @ascopost.bsky.social · 20/07/2026
⚠️ The FDA is warning of an ongoing shortage of stereotactic breast biopsy needles that could affect #breastcancer diagnostic care through early 2027. Providers are being encouraged to conserve supplies, diversify vendors, and communicate possible delays. ow.ly/Apyi50ZeKVP
012
Farzana Ali, MD PhD MPH @fzali.bsky.social · 19/07/2026
Grateful to The Education and Research Foundation & @snm-mi.bsky.social for the 2026 #ERF #SNMMI Travel Award for Physicians, Scientists, and MD/PhD Students. It was a privilege to receive thoughtful feedback from experts, and connect with leaders in the field. @uofcalifornia.bsky.social
Conference attendee standing beside a large digital display showing two research posters at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. The posters present nuclear medicine and theranostics research, including studies on Y-90 radioembolization and Radium-223 therapy. The attendee is wearing a conference badge and is positioned next to the presentation screen in an exhibit hall.
022
Farzana Ali, MD PhD MPH @fzali.bsky.social · 20/06/2026
Truly grateful to the Thakur family and @snm-mi.bsky.social for supporting the 2026 Lalita and Mathew (Madhukar) Thakur Award, in memory of Lalita Thakur, for outstanding work in translational nuclear medicine and molecular imaging. @uofcalifornia.bsky.social #SNMMI #PhysicianScientist #EarlyCareer
Photo from the 2026 SNMMI Annual Meeting showing a person seated at the center holding an award certificate, with two individuals standing on either side. A blue sign in the background reads “2026 Annual Meeting.” The setting is a conference stage with a podium, plants, and dark curtains.
010
Farzana Ali, MD PhD MPH @fzali.bsky.social · 24/05/2026
New Standardized #PSMA #PET Reporting Framework in #Prostate #Cancer! See my latest research highlight in Radiology: Imaging Cancer: pubs.rsna.org/doi/10.1148/... #RadTwitter #NuclearMedicine @rsnasky.bsky.social @rsnatrainees.bsky.social
pubs.rsna.org
New Standardized PSMA PET Reporting Framework for Long-Term Survival Prediction in Prostate Cancer | Radiology: Imaging Cancer
120
Farzana Ali, MD PhD MPH @fzali.bsky.social · 11/05/2026
From Training to Independent Practice in Radiology: Reflections and Early-Career Lessons from Radiology: Imaging Cancer @rsnasky.bsky.social
pubs.rsna.org
From Training to Independent Practice in Radiology: Reflections and Early-Career LessonsRadiology: Imaging Cancer
010
Farzana Ali, MD PhD MPH @fzali.bsky.social · 12/04/2026
🫀Here's our latest editorial on optimizing protocol for ¹⁸F- #Flurpiridaz #PET Myocardial Perfusion Imaging in the Journal of Nuclear Cardiology by @asnc.bsky.social 🆓Access for a limited time: authors.elsevier.com/c/1mvwc3pcK0... Permanent 🔗: doi.org/10.1016/j.nu...
000
Farzana Ali, MD PhD MPH @fzali.bsky.social · 02/04/2026
2025 Manuscript Reviewers: A Note of ThanksRadiology: Imaging Cancer pubs.rsna.org/doi/10.1148/... @rsnasky.bsky.social
pubs.rsna.org
RSNA Journals | Cookie Absent
000
Farzana Ali, MD PhD MPH @fzali.bsky.social · 16/03/2026
Our latest publication on practical access-oriented strategies for expanding #MRI availability in #neuroradiology @theajnr.bsky.social from @asfnr.bsky.social www.ajnr.org/content/earl...
011
Farzana Ali, MD PhD MPH @fzali.bsky.social · 07/03/2026
Check out our latest findings on #Metformin effects on renal function in #mCRPC during #PSMA radiopharmaceutical therapy @ascocancer.bsky.social #GU26 ascopubs.org/doi/abs/10.1... @ascopost.bsky.social
ascopubs.org
Metformin effects on renal function in mCRPC during PSMA radiopharmaceutical therapy (RPT): A retrospective analysis.
203Background: Preclinical research indicates that metformin may mitigate renal accumulation of lutetium-177-labeled PSMA radioligands in metastatic castration-resistant prostate cancer (mCRPC) by inh...
010
Reposted by Farzana Ali, MD PhD MPH
Farzana Ali, MD PhD MPH @fzali.bsky.social · 25/02/2026
For the future of therapy sequencing in advanced prostate cancer @aacrjournals.bsky.social aacrjournals.org/cancerimmuno...
aacrjournals.org
Abstract A031: Systemic Inflammatory Biomarkers and Lu-177-PSMA Radiopharmaceutical Therapy Response in Sipuleucel-T-Pretreated Metastatic Castration-Resistant Prostate Cancer
AbstractPurpose:. To evaluate whether prior sipuleucel-T immunotherapy modifies the relationship between baseline systemic inflammatory biomarkers and Lutetium-177 (177Lu)-labeled prostate-specific me...
141
Farzana Ali, MD PhD MPH @fzali.bsky.social · 25/02/2026
For the future of therapy sequencing in advanced prostate cancer @aacrjournals.bsky.social aacrjournals.org/cancerimmuno...
aacrjournals.org
Abstract A031: Systemic Inflammatory Biomarkers and Lu-177-PSMA Radiopharmaceutical Therapy Response in Sipuleucel-T-Pretreated Metastatic Castration-Resistant Prostate Cancer
AbstractPurpose:. To evaluate whether prior sipuleucel-T immunotherapy modifies the relationship between baseline systemic inflammatory biomarkers and Lutetium-177 (177Lu)-labeled prostate-specific me...
141
Reposted by Farzana Ali, MD PhD MPH
Marzieh Ghiasi, MD PhD @marziehghiasi.com · 08/06/2025
Join APSA on June 18th @ 7PM EDT for a free webinar with physician-scientist experts on how to fund your vision & build your academic profile. Register for FREE here: tinyurl.com/APSAWebinars #residency #physicianscientists #grants #APSA
123